BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Esposito I, Konukiewitz B, Schlitter AM, Klöppel G. Pathology of pancreatic ductal adenocarcinoma: Facts, challenges and future developments. World J Gastroenterol 2014; 20(38): 13833-13841 [PMID: 25320520 DOI: 10.3748/wjg.v20.i38.13833]
URL: https://www.wjgnet.com/1007-9327/full/v20/i38/13833.htm
Number Citing Articles
1
Friederike V. Opitz, Lena Haeberle, Alexandra Daum, Irene Esposito. Tumor Microenvironment in Pancreatic Intraepithelial NeoplasiaCancers 2021; 13(24): 6188 doi: 10.3390/cancers13246188
2
Přemysl Frič, Jan Škrha, Aleksi Šedo, Petr Bušek, Martin Laclav, Bohuš Bunganič, Miroslav Zavoral. Precursors of pancreatic cancerEuropean Journal of Gastroenterology & Hepatology 2017; 29(3): e13 doi: 10.1097/MEG.0000000000000810
3
Ari Kassardjian, Nicholas Stanzione, Hanlin L. Wang. Comparative Accuracy of Tumor Size Assessment and Stage Analysis by Imaging Modalities Versus Gross Examination for Pancreatic Ductal AdenocarcinomaPancreas 2019; 48(2): 223 doi: 10.1097/MPA.0000000000001233
4
Paul J. Kelly. Histopathology Reporting2020; : 55 doi: 10.1007/978-3-030-27828-1_4
5
Davide Busato, Monica Mossenta, Michele Dal Bo, Paolo Macor, Giuseppe Toffoli. The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal AdenocarcinomaInternational Journal of Molecular Sciences 2022; 23(18): 10279 doi: 10.3390/ijms231810279
6
Sang Hyun Choi, Hyoung Jung Kim, Kyung Won Kim, Soyeon An, Seung-Mo Hong, Song Cheol Kim, Myung-Hwan Kim. DPC4 gene expression in primary pancreatic ductal adenocarcinoma: relationship with CT characteristicsThe British Journal of Radiology 2017; 90(1073): 20160403 doi: 10.1259/bjr.20160403
7
Jorge A. Roacho-Pérez, Elsa N. Garza-Treviño, Paulina Delgado-Gonzalez, Zuca G-Buentello, Juan Luis Delgado-Gallegos, Christian Chapa-Gonzalez, Margarita Sánchez-Domínguez, Celia N. Sánchez-Domínguez, Jose Francisco Islas. Target Nanoparticles against Pancreatic Cancer: Fewer Side Effects in TherapyLife 2021; 11(11): 1187 doi: 10.3390/life11111187
8
Khadija El Jellas, Dag Hoem, Kristin G Hagen, May Britt Kalvenes, Sura Aziz, Solrun J Steine, Heike Immervoll, Stefan Johansson, Anders Molven. Associations between ABO blood groups and pancreatic ductal adenocarcinoma: influence on resection status and survivalCancer Medicine 2017; 6(7): 1531 doi: 10.1002/cam4.1097
9
Vimal Arora, Dinesh Kumar Chellappan, Krishnan Anand, Harish Dureja. Advanced Drug Delivery Systems in the Management of Cancer2021; : 243 doi: 10.1016/B978-0-323-85503-7.00030-4
10
Günter Klöppel, Irene Esposito, Atsuko Kasajima, Björn Konukiewitz, Jutta Lüttges, Bence Sipos. PathologiePathologie 2020; : 707 doi: 10.1007/978-3-642-04557-8_24
11
Andrea Cacciato Insilla, Mirella Giordano, Daniela Campani. Pathology of the PancreasEncyclopedia of Pathology 2022; : 130 doi: 10.1007/978-3-030-62416-3_5572
12
Götz M. Richter. Pancreatic Cancer2018; : 681 doi: 10.1007/978-1-4939-7193-0_90
13
Rita Rebelo, Bárbara Polónia, Lúcio Lara Santos, M. Helena Vasconcelos, Cristina P. R. Xavier. Drug Repurposing Opportunities in Pancreatic Ductal AdenocarcinomaPharmaceuticals 2021; 14(3): 280 doi: 10.3390/ph14030280
14
Götz M. Richter. Pancreatic Cancer2018; : 1 doi: 10.1007/978-1-4939-6631-8_90-1
15
Carl Stephan Leonhardt, Willem Niesen, Eva Kalkum, Rosa Klotz, Thomas Hank, Markus Wolfgang Büchler, Oliver Strobel, Pascal Probst. Prognostic relevance of the revised R status definition in pancreatic cancer: meta-analysisBJS Open 2022; 6(2) doi: 10.1093/bjsopen/zrac010
16
Sukhwinder Kaur, Maneesh Jain, Surinder K. Batra. Liquid Biopsy for Identification of High-Risk Cystic Lesions of PancreasGastroenterology 2021; 160(4): 1016 doi: 10.1053/j.gastro.2020.12.039
17
Tobias Piegeler, Thomas Winder, Sabine Kern, Bernhard Pestalozzi, Paul Magnus Schneider, Beatrice Beck-Schimmer. Detection of circulating tumor cells in patients with esophagogastric or pancreatic adenocarcinoma using the CellSearch® system: An observational feasibility studyOncology Letters 2016; 12(2): 1513 doi: 10.3892/ol.2016.4809
18
Qi Zhou, Xufeng Tao, Shilin Xia, Fangyue Guo, Chen Pan, Hong Xiang, Dong Shang. T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00382
19
Enrica Saponara, Michele Visentin, Francesco Baschieri, Gitta Seleznik, Paola Martinelli, Irene Esposito, Johanna Buschmann, Rong Chen, Rossella Parrotta, Nathalie Borgeaud, Marta Bombardo, Ermanno Malagola, Amedeo Caflisch, Hesso Farhan, Rolf Graf, Sabrina Sonda. Serotonin uptake is required for Rac1 activation in Kras-induced acinar-to-ductal metaplasia in the pancreasThe Journal of Pathology 2018; 246(3): 352 doi: 10.1002/path.5147
20
Joseph Carmicheal, Asish Patel, Vipin Dalal, Pranita Atri, Amaninder S. Dhaliwal, Uwe A. Wittel, Mokenge P. Malafa, Geoffrey Talmon, Benjamin J. Swanson, Shailender Singh, Maneesh Jain, Sukhwinder Kaur, Surinder K. Batra. Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s)Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1873(1): 188318 doi: 10.1016/j.bbcan.2019.188318
21
Selvaraj Jayaraman, Bhuvaneswari Ponnusamy, Ponnulakshmi Rajagopal, S. Gowtham Kumar, Kirubhanand Chandrasekar. Handbook of Animal Models and its Uses in Cancer Research2022; : 1 doi: 10.1007/978-981-19-1282-5_39-1
22
Mirella Giordano, Andrea Cacciato Insilla, Daniela Campani. Encyclopedia of PathologyEncyclopedia of Pathology 2021; : 1 doi: 10.1007/978-3-319-28845-1_5533-1
23
Anusha Ande, Maher Chaar, Sihem Ait-Oudhia. Multiscale systems pharmacological analysis of everolimus action in hepatocellular carcinomaJournal of Pharmacokinetics and Pharmacodynamics 2018; 45(4): 607 doi: 10.1007/s10928-018-9590-0
24
Liya Huang, Ting Ye, Jingjing Wang, Xiaojing Gu, Ruiting Ma, Lulu Sheng, Binwu Ma. Identification of Survival-Associated Hub Genes in Pancreatic Adenocarcinoma Based on WGCNAFrontiers in Genetics 2022; 12 doi: 10.3389/fgene.2021.814798
25
Andrew McGuigan, Paul Kelly, Richard C Turkington, Claire Jones, Helen G Coleman, R Stephen McCain. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomesWorld Journal of Gastroenterology 2018; 24(43): 4846-4861 doi: 10.3748/wjg.v24.i43.4846
26
Andrea Cacciato Insilla, Mirella Giordano, Daniela Campani. Encyclopedia of PathologyEncyclopedia of Pathology 2021; : 1 doi: 10.1007/978-3-319-28845-1_5573-1
27
Marta Cáceres, Rita Quesada, Mar Iglesias, Francisco X. Real, Maria Villamonte, Jaime Martinez de Villarreal, Mónica Pérez, Ana Andaluz, Xavier Moll, Enrique Berjano, Dimitri Dorcaratto, Patricia Sánchez-Velázquez, Luís Grande, Fernando Burdío. Pancreatic duct ligation reduces premalignant pancreatic lesions in a Kras model of pancreatic adenocarcinoma in miceScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-74947-4
28
Aditi Kothari, Matthew J. Flick. Coagulation Signaling through PAR1 as a Therapeutic Target in Pancreatic Ductal AdenocarcinomaInternational Journal of Molecular Sciences 2021; 22(10): 5138 doi: 10.3390/ijms22105138
29
Mohamed Badheeb, Adham Abdelrahim, Abdullah Esmail, Godsfavour Umoru, Karen Abboud, Ebtesam Al-Najjar, Ghaith Rasheed, Mohammed Alkhulaifawi, Ala Abudayyeh, Maen Abdelrahim. Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and ScreeningCurrent Oncology 2022; 29(11): 8693 doi: 10.3390/curroncol29110686
30
Mirella Giordano, Andrea Cacciato Insilla, Daniela Campani. Pathology of the PancreasEncyclopedia of Pathology 2022; : 136 doi: 10.1007/978-3-030-62416-3_5533
31
Kelly E. Diaz, Aimee L. Lucas. Familial Pancreatic Ductal AdenocarcinomaThe American Journal of Pathology 2019; 189(1): 36 doi: 10.1016/j.ajpath.2018.06.026
32
Haidi Chen, Qifeng Zhuo, Zeng Ye, Xiaowu Xu, Shunrong Ji. Organoid model: A new hope for pancreatic cancer treatment?Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2021; 1875(1): 188466 doi: 10.1016/j.bbcan.2020.188466
33
Kanan Panchal, Rakesh Kumar Sahoo, Umesh Gupta, Akash Chaurasiya. Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overviewInternational Immunopharmacology 2021; 95: 107508 doi: 10.1016/j.intimp.2021.107508
34
Mark J. Hoenerhoff, Arun Kumar R. Pandiri. Toxicologic Pathology for Non-Pathologists2019; : 137 doi: 10.1007/978-1-4939-9777-0_5
35
John C. Chang, Madappa Kundranda. Novel Diagnostic and Predictive Biomarkers in Pancreatic AdenocarcinomaInternational Journal of Molecular Sciences 2017; 18(3): 667 doi: 10.3390/ijms18030667
36
Björn Konukiewitz, Moritz Jesinghaus, Atsuko Kasajima, Günter Klöppel. Neuroendocrine neoplasms of the pancreas: diagnosis and pitfallsVirchows Archiv 2022; 480(2): 247 doi: 10.1007/s00428-021-03211-5
37
Miguel A. Ortega, Oscar Fraile-Martinez, Leonel Pekarek, Cielo García-Montero, Miguel Angel Alvarez-Mon, Alejandro J. Castellanos, Natalio García-Honduvilla, Julia Buján, Melchor Alvarez-Mon, Miguel A. Sáez, Luis G. Guijarro, Angel Asúnsolo. Oxidative Stress Markers Are Associated with a Poor Prognosis in Patients with Pancreatic CancerAntioxidants 2022; 11(4): 759 doi: 10.3390/antiox11040759
38
Xiao Wang, Wenbin Kuang, Jiayu Ding, Jiaxing Li, Minghui Ji, Weijiao Chen, Hao Shen, Zhongrui Shi, Dawei Wang, Liping Wang, Peng Yang. Systematic Identification of the RNA-Binding Protein STAU2 as a Key Regulator of Pancreatic AdenocarcinomaCancers 2022; 14(15): 3629 doi: 10.3390/cancers14153629
39
Chanjuan Shi, Fong Cheng Pan, Jessica N. Kim, M. Kay Washington, Chandrasekhar Padmanabhan, Christian T. Meyer, Janel L. Kopp, Maike Sander, Maureen Gannon, R. Daniel Beauchamp, Christopher V. Wright, Anna L. Means. Differential Cell Susceptibilities to Kras in the Setting of Obstructive Chronic PancreatitisCellular and Molecular Gastroenterology and Hepatology 2019; 8(4): 579 doi: 10.1016/j.jcmgh.2019.07.001
40
Guillermo Urrutia, Thiago Milech de Assuncao, Angela J. Mathison, Ann Salmonson, Romica Kerketta, Atefeh Zeighami, Timothy J. Stodola, Volkan Adsay, Burcin Pehlivanoglu, Michael B. Dwinell, Michael T. Zimmermann, Juan L. Iovanna, Raul Urrutia, Gwen Lomberk. Inactivation of the Euchromatic Histone-Lysine N-Methyltransferase 2 Pathway in Pancreatic Epithelial Cells Antagonizes Cancer Initiation and Pancreatitis-Associated Promotion by Altering Growth and Immune Gene Expression NetworksFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.681153
41
Andrea Cacciato Insilla, Mirella Giordano, Daniela Campani. Pathology of the PancreasEncyclopedia of Pathology 2022; : 132 doi: 10.1007/978-3-030-62416-3_5573
42
M. Ducreux, A. Sa. Cuhna, C. Caramella, A. Hollebecque, P. Burtin, D. Goéré, T. Seufferlein, K. Haustermans, J.L. Van Laethem, T. Conroy, D. Arnold. Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology 2015; 26: v56 doi: 10.1093/annonc/mdv295
43
Michael Friberg Bruun Nielsen, Michael Bau Mortensen, Sönke Detlefsen. Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cellsWorld Journal of Gastroenterology 2016; 22(9): 2678-2700 doi: 10.3748/wjg.v22.i9.2678
44
Anna Melissa Schlitter, Björn Konukiewitz, Atsuko Kasajima, Maximilian Reichert, Günter Klöppel. Das duktale Adenokarzinom des Pankreas: Subtypen und MolekularpathologieDer Pathologe 2021; 42(5): 464 doi: 10.1007/s00292-021-00965-2
45
Miguel A. Ortega, Leonel Pekarek, Oscar Fraile-Martinez, Cielo Garcia-Montero, Miguel A. Saez, Angel Asúnsolo, Miguel A. Alvarez-Mon, Jorge Monserrat, Lidia Ruiz-Llorente, Natalio García-Honduvilla, Agustin Albillos, Julia Buján, Melchor Alvarez-Mon, Luis G. Guijarro. Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological StudiesCurrent Oncology 2022; 29(4): 2442 doi: 10.3390/curroncol29040198
46
Anna Melissa Schlitter, Angela Segler, Katja Steiger, Christoph W. Michalski, Carsten Jäger, Björn Konukiewitz, Nicole Pfarr, Volker Endris, Markus Bettstetter, Bo Kong, Ivonne Regel, Jörg Kleeff, Günter Klöppel, Irene Esposito. Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): Identification of prognostic subtypesScientific Reports 2017; 7(1) doi: 10.1038/srep41064
47
Andrea Cacciato Insilla, Mirella Giordano, Daniela Campani. Encyclopedia of PathologyEncyclopedia of Pathology 2021; : 1 doi: 10.1007/978-3-319-28845-1_5574-1
48
Zhaoyan Qiu, Yi Chu, Bing Xu, Qian Wang, Mingzuo Jiang, Xiaowei Li, Gang Wang, Pengfei Yu, Guoxiao Liu, Hua Wang, Huijie Kang, Jiayu Liu, Yu Zhang, Jian-Ping Jin, Kaichun Wu, Jie Liang. Increased expression of calponin 2 is a positive prognostic factor in pancreatic ductal adenocarcinomaOncotarget 2017; 8(34): 56428 doi: 10.18632/oncotarget.17701
49
Yusuke Fujita, Minoru Kitago, Yohei Masugi, Osamu Itano, Masahiro Shinoda, Yuta Abe, Taizo Hibi, Hiroshi Yagi, Yoko Fujii-Nishimura, Michiie Sakamoto, Yuko Kitagawa. Two cases of pancreatic ductal adenocarcinoma with intrapancreatic metastasisWorld Journal of Gastroenterology 2016; 22(41): 9222-9228 doi: 10.3748/wjg.v22.i41.9222
50
Jia Yao, Man Yang, Lawrence Atteh, Pinyan Liu, Yongcui Mao, Wenbo Meng, Xun Li. A pancreas tumor derived organoid study: from drug screen to precision medicineCancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02044-1
51
Linying Chen, Xiao Xu, Xinxin Wen, Shenmin Xu, Long Wang, Wenxian Lu, Mingting Jiang, Jing Huang, Dayun Yang, Jichuang Wang, Min Zheng, Xiao Zhen Zhou, Kun Ping Lu, Hekun Liu. Targeting PIN 1 exerts potent antitumor activity in pancreatic ductal carcinoma via inhibiting tumor metastasis Cancer Science 2019; 110(8): 2442 doi: 10.1111/cas.14085
52
Linning E, Yan Xu, Zhifeng Wu, Li Li, Na Zhang, Hao Yang, Lawrence H. Schwartz, Lin Lu, Binsheng Zhao. Differentiation of Focal-Type Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma Using Radiomics Based on Multiphasic Computed TomographyJournal of Computer Assisted Tomography 2020; 44(4): 511 doi: 10.1097/RCT.0000000000001049
53
S Roshni, AL Lijeesh, J Jose, A Mathew. Evaluation of Treatment Outcome and Acute Toxicity in Patients Undergoing Adjuvant Therapy in Ductal Carcinoma Pancreas: A Prospective Observational StudyEMJ Oncology 2021; : 72 doi: 10.33590/emjoncol/21-00018
54
Andrea Cacciato Insilla, Mirella Giordano, Daniela Campani. Pathology of the PancreasEncyclopedia of Pathology 2022; : 126 doi: 10.1007/978-3-030-62416-3_5574
55
Leticia Moreira, Basil Bakir, Priya Chatterji, Zahra Dantes, Maximilian Reichert, Anil K. Rustgi. Pancreas 3D Organoids: Current and Future Aspects as a Research Platform for Personalized Medicine in Pancreatic CancerCellular and Molecular Gastroenterology and Hepatology 2018; 5(3): 289 doi: 10.1016/j.jcmgh.2017.12.004
56
Glancis Luzeena Raja Arul, Merih D. Toruner, Robert A. Gatenby, Ryan M. Carr. Ecoevolutionary biology of pancreatic ductal adenocarcinomaPancreatology 2022; 22(6): 730 doi: 10.1016/j.pan.2022.06.005
57
Andrea Cacciato Insilla, Mirella Giordano, Daniela Campani. Encyclopedia of PathologyEncyclopedia of Pathology 2021; : 1 doi: 10.1007/978-3-319-28845-1_5572-1
58
Jonghyeob Lee, Emily R. Snyder, Yinghua Liu, Xueying Gu, Jing Wang, Brittany M. Flowers, Yoo Jung Kim, Sangbin Park, Gregory L. Szot, Ralph H. Hruban, Teri A. Longacre, Seung K. Kim. Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cellsNature Communications 2017; 8(1) doi: 10.1038/ncomms14686
59
Na Li, Fan Yang, Dong-Yan Liu, Jin-Tao Guo, Nan Ge, Si-Yu Sun. Scoparone inhibits pancreatic cancer through PI3K/Akt signaling pathwayWorld Journal of Gastrointestinal Oncology 2021; 13(9): 1164-1183 doi: 10.4251/wjgo.v13.i9.1164